| 1. | Suppression of angiotensin II leads to a decrease in aldosterone levels.
|
| 2. | Aldosterone and corticosterone share the first part of their biosynthetic pathway.
|
| 3. | Aldosterone and corticosterone share the first part of their biosynthetic pathways.
|
| 4. | Measuring aldosterone alone is not considered adequate to diagnose primary hyperaldosteronism.
|
| 5. | Because of the normal aldosterone level, hypertension is not expected.
|
| 6. | Synthesis of aldosterone is also dependent on 21-hydroxylase activity.
|
| 7. | DOC has a similar feedback with respect to potassium as aldosterone.
|
| 8. | ACTH has more effect on DOC than it does on aldosterone.
|
| 9. | Some patients must also take a synthetic form of aldosterone, fludrocortisone.
|
| 10. | The aldosterone system is directly targeted by spironolactone, an aldosterone antagonist.
|
मोबाइल